The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves hormones through blood and spinal fluid, misfolded ...

Qure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1, uniQure’s Phase I/II clinical trial of AMT-162, an ...

These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

Proteins, the pillars of cellular function, often assemble into 'complexes' to fulfill their functions. A study reveals why this assembly often begins during the very process of protein synthesis or ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

ProMIS Neurosciences Inc., a clinical-stage biopharmaceutical company, made significant disclosures in its recent 8-K filing with the Securities and Exchange Commission. In its filing dated January 27 ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves ...

The formation of protein complexes is a delicate process, with some proteins finding their match at synthesis.